P2Y12 blocker monotherapy after percutaneous coronary intervention

For secondary prevention of coronary artery disease (CAD) antiplatelet therapy is essential. For patients undergoing a percutaneous coronary intervention (PCI) temporary dual antiplatelet platelet therapy (DAPT: aspirin combined with a P2Y12 blocker) is mandatory, but leads to more bleeding than sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Verheugt, F. W. A., Damman, P., Damen, S. A. J., Wykrzykowska, J. J., Woelders, E. C. I., van Geuns, R. -J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556441/
https://www.ncbi.nlm.nih.gov/pubmed/34101134
http://dx.doi.org/10.1007/s12471-021-01582-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556441/
https://www.ncbi.nlm.nih.gov/pubmed/34101134
http://dx.doi.org/10.1007/s12471-021-01582-7

Ejemplares similares